Indegene Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Indegene Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 18.8 times. Higher than 96% of Healthcare companies in India.
- Tangible Assets Ratio: Of every ₹100 the company owns, ₹65 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 93% of Healthcare companies in India.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 9% of its market value (net cash). Higher than 91% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹140Over the last 3 years, every ₹100 of reported profit came with ₹140 of operating cash.
Higher than 67% of Healthcare companies in India.
Self-Funding Ratio
18.8×Over the last 3 years its own operating cash covered its investment spending (capex) 18.8 times.
Higher than 96% of Healthcare companies in India.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹11Sales grew 52% in 3 years; of every extra ₹100 of sales, ₹11 became extra profit.
Lower than 65% of Healthcare companies in India.
Asset Productivity Ratio
+52% / +110%In 3 years sales changed by +52% while total assets changed by +110%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
16.5×Debt due within a year is covered 16.5 times by its yearly operating cash.
Higher than 81% of Healthcare companies in India.
Cash Cushion Ratio
+9%Cash, after subtracting all debt, equals 9% of its market value (net cash).
Higher than 91% of Healthcare companies in India.
Tangible Assets Ratio
65%Of every ₹100 the company owns, ₹65 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 93% of Healthcare companies in India.
Tangible Net Worth Ratio
48%Of every ₹100 of net worth, ₹48 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 88% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Indegene Limited owes ₹0.32 for every ₹1 it owns. Net profit fell 1% in the year to Mar 2026, and grew 15% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
34.5Investors pay ₹34.5 for every ₹1 of Indegene Limited's yearly profit, lower than 54% of Healthcare companies in India.
P/B ratio
4.39The share price is 4.39 times Indegene Limited's book value per share, lower than 54% of Healthcare companies in India.
Market cap
₹13,773 CrThe total market value of all of Indegene Limited's shares at today's price (share price × number of shares), larger than 68% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹3,139 CrWhat Indegene Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹130.33Net worth divided by the number of shares. The share price of ₹571.90 is 4.4 times this, which is the P/B above.
Return on equity (ROE)
12.7%Indegene Limited earned 12.7% on its shareholders' money over the last year, higher than 50% of Healthcare companies in India.
Owes vs Owns
0.32×Indegene Limited owes ₹0.32 for every ₹1 it owns (low), lower than 63% of Healthcare companies in India.
Dividend yield
0.39%Indegene Limited pays 0.39% of its share price as dividends a year, higher than 53% of dividend-paying Healthcare companies in India.
Revenue growth
+24%Revenue rose 24% in the year to Mar 2026, and grew 15% a year on average over 3 years.
Profit growth
-1%Net profit fell 1% in the year to Mar 2026, and grew 15% a year on average over 3 years.
Profit margin
11.4%Indegene Limited keeps ₹11 of every ₹100 of revenue as net profit.
Cash quality
1.6×Cash from Indegene Limited's business was 1.6× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
31.1×Indegene Limited's operating profit covered its interest costs 31.1 times in the year to Mar 2026.
Cash vs debt
Net cashIndegene Limited held ₹1,337 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Indegene Limited's P/E ratio?
Investors pay ₹34.5 for every ₹1 of Indegene Limited's yearly profit, lower than 54% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Indegene Limited: ₹13,773 Cr ÷ ₹3,139 Cr (31 Mar 2026) = 4.4.
What is Indegene Limited's return on equity?
Indegene Limited earned 12.7% on its shareholders' money over the last year, higher than 50% of Healthcare companies in India.
How much does Indegene Limited owe compared with what it owns?
Indegene Limited owes ₹0.32 for every ₹1 it owns (low), lower than 63% of Healthcare companies in India.
Does Indegene Limited pay a dividend?
Yes. Indegene Limited pays 0.39% of its share price as dividends a year, higher than 53% of dividend-paying Healthcare companies in India.
Is Indegene Limited's revenue growing?
Revenue rose 24% in the year to Mar 2026, and grew 15% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.